The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities.
Saved in:
| Title: | The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities. |
|---|---|
| Authors: | Zielli T; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland., Labidi-Galy I; Department of Oncology, Geneva University Hospitals, Geneva 1205, Switzerland.; Department of Medicine, Center of Translational Research in Onco-Hematology, Geneva 1205, Switzerland., Del Grande M; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland., Sessa C; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland., Colombo I; Service of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona 6500, Switzerland. |
| Source: | Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2023 Jul 28; Vol. 6 (3), pp. 499-516. Date of Electronic Publication: 2023 Jul 28 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2578-532X |
|---|---|
| DOI: | 10.20517/cdr.2023.08 |
